Neurodevelopmental outcome of preterm infants enrolled in myo-inositol randomized controlled trial
dc.contributor.author | Adams-Chapman, Ira | |
dc.contributor.author | Watterberg, Kristi L. | |
dc.contributor.author | Nolen, Tracy L. | |
dc.contributor.author | Hirsch, Shawn | |
dc.contributor.author | Cole, Carol A. | |
dc.contributor.author | Cotten, C. Michael | |
dc.contributor.author | Oh, William | |
dc.contributor.author | Poindexter, Brenda B. | |
dc.contributor.author | Zaterka-Baxter, Kristin M. | |
dc.contributor.author | Das, Abhik | |
dc.contributor.author | Backstrom Lacy, Conra | |
dc.contributor.author | Scorsone, Ann Marie | |
dc.contributor.author | Duncan, Andrea F. | |
dc.contributor.author | DeMauro, Sara B. | |
dc.contributor.author | Goldstein, Ricki F. | |
dc.contributor.author | Colaizy, Tarah T. | |
dc.contributor.author | Wilson-Costello, Deanne E. | |
dc.contributor.author | Purdy, Isabell B. | |
dc.contributor.author | Hintz, Susan R. | |
dc.contributor.author | Heyne, Roy J. | |
dc.contributor.author | Myers, Gary J. | |
dc.contributor.author | Fuller, Janell | |
dc.contributor.author | Merhar, Stephanie | |
dc.contributor.author | Harmon, Heidi M. | |
dc.contributor.author | Peralta-Carcelen, Myriam | |
dc.contributor.author | Kilbride, Howard W. | |
dc.contributor.author | Maitre, Nathalie L. | |
dc.contributor.author | Vohr, Betty R. | |
dc.contributor.author | Natarajan, Girija | |
dc.contributor.author | Mintz-Hittner, Helen | |
dc.contributor.author | Quinn, Graham E. | |
dc.contributor.author | Wallace, David K. | |
dc.contributor.author | Olson, Richard J. | |
dc.contributor.author | Orge, Faruk H. | |
dc.contributor.author | Tsui, Irena | |
dc.contributor.author | Gaynon, Michael | |
dc.contributor.author | Hutchinson, Amy K. | |
dc.contributor.author | He, Yu-Guang | |
dc.contributor.author | Winter, Timothy W. | |
dc.contributor.author | Yang, Michael B. | |
dc.contributor.author | Haider, Kathryn M. | |
dc.contributor.author | Cogen, Martin S. | |
dc.contributor.author | Hug, Denise | |
dc.contributor.author | Bremer, Don L. | |
dc.contributor.author | Donahue, John P. | |
dc.contributor.author | Lucas, William R. | |
dc.contributor.author | Phelps, Dale L. | |
dc.contributor.author | Higgins, Rosemary D. | |
dc.contributor.author | Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network | |
dc.contributor.department | Pediatrics, School of Medicine | |
dc.date.accessioned | 2023-08-11T20:10:56Z | |
dc.date.available | 2023-08-11T20:10:56Z | |
dc.date.issued | 2021 | |
dc.description.abstract | Objective: This study evaluates the 24-month follow-up for the NICHD Neonatal Research Network (NRN) Inositol for Retinopathy Trial. Study design: Bayley Scales of Infants Development-III and a standardized neurosensory examination were performed in infants enrolled in the main trial. Moderate/severe NDI was defined as BSID-III Cognitive or Motor composite score <85, moderate or severe cerebral palsy, blindness, or hearing loss that prevents communication despite amplification were assessed. Results: Primary outcome was determined for 605/638 (95%). The mean gestational age was 25.8 ± 1.3 weeks and mean birthweight was 805 ± 192 g. Treatment group did not affect the risk for the composite outcome of death or survival with moderate/severe NDI (60% vs 56%, p = 0.40). Conclusions: Treatment group did not affect the risk of death or survival with moderate/severe NDI. Despite early termination, this study represents the largest RCT of extremely preterm infants treated with myo-inositol with neurodevelopmental outcome data. | |
dc.eprint.version | Author's manuscript | |
dc.identifier.citation | Adams-Chapman I, Watterberg KL, Nolen TL, et al. Neurodevelopmental outcome of preterm infants enrolled in myo-inositol randomized controlled trial. J Perinatol. 2021;41(8):2072-2087. doi:10.1038/s41372-021-01018-5 | |
dc.identifier.uri | https://hdl.handle.net/1805/34862 | |
dc.language.iso | en_US | |
dc.publisher | Springer Nature | |
dc.relation.isversionof | 10.1038/s41372-021-01018-5 | |
dc.relation.journal | Journal of Perinatology | |
dc.rights | Publisher Policy | |
dc.source | PMC | |
dc.subject | Cerebral Palsy | |
dc.subject | Child development | |
dc.subject | Gestational age | |
dc.subject | Extremely premature infant | |
dc.subject | Inositol | |
dc.title | Neurodevelopmental outcome of preterm infants enrolled in myo-inositol randomized controlled trial | |
dc.type | Article |